Efficacy of Buzhong Yiqi Decoction in the Treatment of Ocular Myopathy Myasthenia Gravis (MG) Patients with Spleen and Kidney Deficiency Type: a Randomized Controlled Trial

Affiliated Jiangmen Traditional Chinese Medicine Hospital of Ji'nan University0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Meets the diagnostic criteria of Western medicine for myasthenia gravis, as well as the diagnosis and syndrome differentiation criteria of Chinese medicine;
•2. Patients classified as ocular myasthenia gravis according to the modified Osserman classification;
•3. Aged less than 80 years;
•4. After understanding the contents of this study in detail, the patients voluntarily accepted observation and signed the informed consent.

•1. Patients with myasthenia gravis receiving high dose of corticosteroids or other immunosuppressive agents;
•2. Patients who have had myasthenia crisis or are experiencing myasthenia in the past 1 month;
•3. Severe mental disorders cannot cooperate with clinical investigators;
•4. Patients with other neuromuscular diseases or peripheral nerve diseases;
•5. Patients complicated with serious primary diseases such as cardiovascular, cerebrovascular, respiratory, digestive or endocrine systems, as well as patients complicated with autoimmune diseases or mental illnesses;
•6. Pregnant or lactating women and people with allergies.

发起方

Affiliated Jiangmen Traditional Chinese Medicine Hospital of Ji'nan University